Navigation Links
Pitt-led research provides insight into development of congenital circulatory defects
Date:7/8/2008

ped AVMs on the side of the dead-end vesselleft, right, or boththat happened to receive blood flow first.

While AVMs in humans are generally thought to form in utero, they typically are discovered only when they cause a serious health problem later in life. AVMs can form in various organs, including the brain, lungs, spinal cord, and liver. By diverting blood, the misconnections rob parts of the body of nutrients and oxygen. The fragile fusions are prone to rupturing and hemorrhaging; a ruptured AVM in the brain can cause a stroke.

"We discover AVMs in humans when something goes wrong and we can never go back and trace the shunt's development," Roman said. "Only when we fully understand the mechanisms leading to these malformations will we be able to develop better diagnostic tests and preventative treatments to pinpoint the best time to intervene."


'/>"/>

Contact: Morgan Kelly
mekelly@pitt.edu
412-624-4356
University of Pittsburgh
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery
2. Orange County research program aims to improve severe trauma survival rates
3. Autism Research Institute Launches Mobile Website
4. Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis
5. Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination
6. New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin
7. Ivy Foundation Funds New Brain Cancer Research Consortium : $3M Stage I Project Aims to Improve Personalized Medicine for Patients
8. The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary
9. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
10. Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
11. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...fter receiving organ transplants from a single don...ralia. Upon examination of tissue samples the caus... in the victims’ bodies. The virus was traced in...ourne who died in the few weeks following the tran...
...that had been sweeping across Orissa for the past ...e result of the soaring temperature which// has cr..., officials said. The western town of Sundergarh ...he western towns of Bhabanipatna, Bolangir and the...
...etables are the most preferred by children and the...hers interviewed parents of 1,658 children aged tw... them about their family's diet, including homegro... The study, published in April's journal of the Am...
...onal Development Secretary Hilary Benn on Wednesda...cines// Transparency Alliance -- an initiative tha...including HIV/AIDS, tuberculosis and malaria treat...inancial Times reports. MeTA aims to improve acc...
Other Medicine News:
(Date:10/13/2008)...re/ -- Neuronascent, Inc.,( http://www.neuronascen...ved,funding from multiple sources to further the d...eting Alzheimer,s disease, depression and,ischemia...m Maryland,Department of Business and Economic Dev...dustrial Partnerships in collaboration with Univer...
(Date:10/13/2008)...re/ -- Facet Solutions, Inc. today,announced the c... its US,IDE Pilot Study. The results show a 78% re... and an 80% reduction in Visual Analog Scores (VAS... & CEO for Facet Solutions,added, "We are very pl...,only demonstrate significant pain relief but the ...
(Date:10/10/2008)...swire/ -- Diplomat Specialty,Pharmacy announced to...pecialty Pharmacy to be one of only three sites to...timization Study for Multiple Sclerosis (TOP MS).,...amine the benefits of a,specialty pharmacy therapy...atient outcomes. Targeted patient outcomes will in...
(Date:10/9/2008)...wareness and Bring Hope to Millions,of Children in... -- 133 million children,across the globe are with...saster, civil war, and disease. SOS Children,s Vil... by calling attention to the needs of orphans,worl...o:, http://www.prnewswire.com/mnr/soschildrensvi...
Breaking Medicine Technology:Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs 2Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 1University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 3Virtual game helps children escape realities of burn unit 3211 1Virtual game helps children escape realities of burn unit 3211 2Professor Sir Martin Evans wins Nobel Prize for Medicine 726 1Professor Sir Martin Evans wins Nobel Prize for Medicine 726 2Nursesavvy com Promoting Quality Healthcare for Everyone 3206 1Nursesavvy com Promoting Quality Healthcare for Everyone 3206 2
...007 /PRNewswire-FirstCall/ -- ZymoGenetics,Inc. t...d from a,Phase 1b clinical trial with atacicept in...e American Society of Clinical,Oncology (ASCO) 200...dministration of higher doses than had been tested...as well-tolerated and biologically,active at all d...
...SINESS WIRE)--Jun 4, 2007 - Acorda,Therapeutics, I...pany presented a "meta-analysis" or combined analy...tiple sclerosis during a,poster session at the Ame...ACTRIMS) Meeting in Washington, D.C. on Saturday, ...t Improvement in Walking,Speed on the Timed 25 Foo...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
Sugar-Chex Linearity is a whole blood formulation designed to cover the linear reportable range of the most popular glucose meters. The product meets CAP recommendations of using a control matrix tha
Medicine Products: